… in PD pathology that may result from an inadequate response to toxic, oxidant or inflammatory agents in the basal … to these agents, the so-called phase II response. There are compelling evidences from basic and clinical studies … we explore a new approach to neuroprotection based on targeting the transcription factor Nrf2 pharmacologically with …

… strengthen the heart and bones, boosts mood and energy, and combats illness. For people with Parkinson's disease (PD), … and increasingly affect quality of life. A recent study showed that exercising just 2.5 hours per week could help … , published in the Journal of Parkinson's Disease , monitored the self-reported exercise of more than 3,400 people …

… New Study Linking League Players to Higher Risk of Death by Alzheimer’s and ALS Released on … a result of certain diseases that damage brain cells when compared with the general population.  Their risk of dying … injuries and dying from Parkinson’s disease (PD) was not shown to be significant in this particular study, work …

… This week, more than 12,000 are expected to attend the  American Academy of Neurology 's (AAN) Annual … pressure, as well as in dizziness and lightheadedness, when compared to placebo after one week of treatment. However, when tested over a period of more than a week, the …

… Otis Peeples and his wife, Linda “I’ve hurt myself falling out of bed, while still asleep, and that is … own risk for Parkinson’s disease. PPMI collects information from participants with and without Parkinson’s over time. Otis has been completing tests and sharing biological samples (e.g., …

… disease. Our study will produce proteins called cytokines that play a role in the immune response to determine … be used to measure Parkinson’s or point to a new way to stop the disease. Hypothesis: We hypothesize that people … production by adaptive immune cells. We will explore how to dampen pro-inflammatory responses in these cells. …